Literature DB >> 21373784

Joint hypermobility syndrome: problems that require psychological intervention.

C Baeza-Velasco1, M C Gély-Nargeot, A Bulbena Vilarrasa, J F Bravo.   

Abstract

Joint hypermobility syndrome (JHS), also known as Ehlers-Danlos III, is an inherited disorder of connective tissue, characterised by an exceptional increase in the joint's mobility and the presence of musculoskeletal and other symptoms. It is a benign syndrome if compared with the other types of Ehlers-Danlos, but it can become disabling particularly because it is a significant source of pain and distress. The purpose of this work is to describe some common problems in JHS that render psychological intervention in their overall management relevant. Chronic pain, associated psychopathological factors such as anxiety, depression and somatosensory amplification, and problems arising from a lack of recognition and knowledge of the syndrome, are frequent among those affected, having a negative impact on their quality of life. We emphasise the relevance of addressing JHS from a biopsychosocial approach.

Entities:  

Mesh:

Year:  2011        PMID: 21373784     DOI: 10.1007/s00296-011-1839-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

Review 1.  Heritable disorders of connective tissue.

Authors:  R Grahame
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  2000-06       Impact factor: 4.098

2.  Living with the hypermobility syndrome.

Authors:  S Gurley-Green
Journal:  Rheumatology (Oxford)       Date:  2001-05       Impact factor: 7.580

3.  No evidence for DUP25 in patients with panic disorder using a quantitative real-time PCR approach.

Authors:  Johannes Schumacher; Andreas C J Otte; Tim Becker; Yuli Sun; Thomas F Wienker; Brunhilde Wirth; Petra Franke; Rami Abou Jamra; Peter Propping; Jürgen Deckert; Markus M Nöthen; Sven Cichon
Journal:  Hum Genet       Date:  2003-09-25       Impact factor: 4.132

4.  Benign joint hypermobility syndrome: psychological features and psychopathological symptoms in a sample pain-free at evaluation1.

Authors:  Mauro Ercolani; Matteo Galvani; Cristina Franchini; Federica Baracchini; Rabih Chattat
Journal:  Percept Mot Skills       Date:  2008-08

5.  Association between psychopathological factors and joint hypermobility syndrome in a group of undergraduates from a French university.

Authors:  Carolina Baeza-Velasco; Marie-Christine Gely-Nargeot; Antonio Bulbena Vilarrasa; Caroline Fenetrier; Jaime F Bravo
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

Review 6.  Chronic pain-associated depression: antecedent or consequence of chronic pain? A review.

Authors:  D A Fishbain; R Cutler; H L Rosomoff; R S Rosomoff
Journal:  Clin J Pain       Date:  1997-06       Impact factor: 3.442

Review 7.  Pain, distress and joint hyperlaxity.

Authors:  R Grahame
Journal:  Joint Bone Spine       Date:  2000       Impact factor: 4.929

8.  Joint hypermobility syndrome and anxiety disorders.

Authors:  A Bulbena; J C Duro; A Mateo; M Porta; J Vallejo
Journal:  Lancet       Date:  1988-09-17       Impact factor: 79.321

9.  The hypermobility syndrome. Musculoskeletal complaints associated with generalized joint hypermobility.

Authors:  J A Kirk; B M Ansell; E G Bywaters
Journal:  Ann Rheum Dis       Date:  1967-09       Impact factor: 19.103

10.  The relationship between frequency and intensity of fears and a collagen condition.

Authors:  A Bulbena; J Gago; L Sperry; D Bergé
Journal:  Depress Anxiety       Date:  2006       Impact factor: 6.505

View more
  14 in total

1.  Pain and gastrointestinal dysfunction are significant associations with psychiatric disorders in patients with Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective study.

Authors:  S Wasim; J S Suddaby; M Parikh; S Leylachian; B Ho; A Guerin; J So
Journal:  Rheumatol Int       Date:  2019-03-28       Impact factor: 2.631

2.  Low- and high-anxious hypermobile Ehlers-Danlos syndrome patients: comparison of psychosocial and health variables.

Authors:  Carolina Baeza-Velasco; Caroline Bourdon; Lucile Montalescot; Cécile de Cazotte; Guillem Pailhez; Antonio Bulbena; Claude Hamonet
Journal:  Rheumatol Int       Date:  2018-03-01       Impact factor: 2.631

3.  Is pain the only symptom in patients with benign joint hypermobility syndrome?

Authors:  İlknur Albayrak; Halim Yilmaz; Halil Ekrem Akkurt; Ali Salli; Gülten Karaca
Journal:  Clin Rheumatol       Date:  2014-04-18       Impact factor: 2.980

Review 4.  Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder.

Authors:  Yael Gazit; Giris Jacob; Rodney Grahame
Journal:  Rambam Maimonides Med J       Date:  2016-10-31

5.  Mind the gaps: therapists' experiences of managing symptomatic hypermobility in Scotland.

Authors:  Dervil M Dockrell; Kathryn M Berg; Stuart H Ralston
Journal:  Rheumatol Adv Pract       Date:  2021-07-21

6.  Outcome measures for assessing change over time in studies of symptomatic children with hypermobility: a systematic review.

Authors:  Muhammad Maarj; Andrea Coda; Louise Tofts; Cylie Williams; Derek Santos; Verity Pacey
Journal:  BMC Pediatr       Date:  2021-11-29       Impact factor: 2.125

7.  Altering Dynamics of Autonomic Processing Therapy (ADAPT) trial: a novel, targeted treatment for reducing anxiety in joint hypermobility.

Authors:  Geoff Davies; Jenny L L Csecs; Heather Ball; Jess Dare; Stephen Bremner; Robin Hosking; Hugo D Critchley; Nick Grey; Jessica A Eccles
Journal:  Trials       Date:  2021-09-21       Impact factor: 2.279

8.  Evaluation of kinesiophobia and its correlations with pain and fatigue in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type.

Authors:  Claudia Celletti; Marco Castori; Giuseppe La Torre; Filippo Camerota
Journal:  Biomed Res Int       Date:  2013-07-14       Impact factor: 3.411

9.  Study protocol for a multicentre randomized controlled trial on effectiveness of an outpatient multimodal rehabilitation program for adolescents with chronic musculoskeletal pain (2B Active).

Authors:  Carolien Dekker; Mariëlle E J B Goossens; Caroline H G Bastiaenen; Jeanine A M C F Verbunt
Journal:  BMC Musculoskelet Disord       Date:  2016-07-28       Impact factor: 2.362

10.  Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.

Authors:  Marco Ritelli; Marina Venturini; Valeria Cinquina; Nicola Chiarelli; Marina Colombi
Journal:  Orphanet J Rare Dis       Date:  2020-07-31       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.